0452 : MTOR inactivation during early postnatal development of mice myocardium leads to severe dilated cardiomyopathy due to altered translational efficiency and hypoxia-induced apoptosis  by Bowyer, Laetitia Mazelin et al.
© Elsevier Masson SAS. All rights reserved.
 
192 Archives of Cardiovascular Diseases Supplements (2015) 7, 192-193
Topic 30 – Cardiac and vascular 
signalling – B
0270
CaMKII inhibition prevents cardiac arrhythmias elicited by phospho-
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β-adrenoceptors (β-AR) stimulation increases cardiac function by rising
cAMP that activates protein kinase A (PKA) and enhances Ca2+-induced Ca2+-
release by phosphorylating proteins such as ryanodine receptors and phosphol-
amban, which are also targets of the Ca2+/Calmodulin Kinase II (CaMKII). Any
dysregulation of the β-AR pathway promotes arrhythmias. Local cAMP concen-
tration in heart is mainly regulated by phosphodiesterases (PDE) type 3 and 4.
Here, we investigated the proarrhythmic effects of PDE3 and PDE4 inhibition
and evaluated the relative contribution of PKA and CaMKII to these mecha-
nisms. An IonOptix system was used to record intracellular Ca2+ transients in
isolated adult rat and pig ventricular myocytes (ARVMs and APVMs) loaded
with 1μM Fura-2AM and paced at 1Hz. In ARVMs, PDE4 inhibition with
Ro20-1724 (Ro, 10μM) potentiated the inotropic effect of the β-AR agonist iso-
proterenol (Iso, 1nM) but induced spontaneous Ca2+ waves (SCWs) recorded
during 10s pacing pauses (2.3±0.2 SCWs/10s, n=15; p<0.001). Sarcoplasmic
reticulum (SR) Ca2+ load increased by 30±5% (n=13; p<0.001) in Iso, but dou-
bled (p<0.001) in Iso+Ro leading to SR Ca2+ leak (measured in a 0Na+,0Ca2+
solution±1mM tetracaine, n=7; p<0.001). PKA inhibition by H89 (10μM) sup-
pressed SCWs, SR Ca2+ leak and the inotropic effect of Iso±Ro. The CaMKII
inhibitor KN93 (10μM), unlike its inactive analogue KN92, reduced SR Ca2+
leak by 85% (n=16; p<0.001) and SCWs incidence by 72% (n=8; p<0.001)
without affecting the inotropic effect of Iso+Ro. KN93 blunted the SR Ca2+ leak
induced by PDE3 inhibition with cilostamide (Cil, 1μM, n=10; p<0.001) by
81% but preserved Ca2+ transients amplitude. Similarly, CaMKII inhibition pre-
vented SCWs evoked by Cil and Ro in APVMs.
These results show that PDE inhibitors exert inotropic effects via PKA but
lead to SCWs via both PKA and CaMKII activation. They also suggest the
potential use of CaMKII inhibitors as adjuncts to PDE inhibitors to limit their
proarrhythmic effects.
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Background: A key detrimental characteristic of left ventricular (LV)
remodelling is fibrosis. The pathogenesis of cardiac fibrosis includes migra-
tion of cardiac fibroblasts. Remodelling of actin cytoskeleton is a hallmark of
the migrating cells. AMP-activated protein kinase (AMPK) regulates actin
cytoskeleton organization and has been shown to influence LV remodelling.
In this study, we investigated whether A-769662, a pharmacological AMPK
activator, modulates human cardiac fibroblast (HCF) migration and adhesion
by affecting actin organization.
Methods: Single-cell migration was assessed by time-lapse imaging. Focal
adhesions (FA) were visualized by immunofluorescence together with fluores-
cent phalloidin to stain actin filaments. Phosphorylation state of myosin regu-
latory light chains (MLC) was determined by western blot analysis and
immunofluorescent staining. RhoA activity was assessed using a pull down
method.
Results: A-769662 significantly decreased HCF motility, in an AMPKα1-
dependent manner. In addition, A-769662-treated cells shifted from an elon-
gated shape, characterized by leading and trailing edges, to a more polygonal
one with numerous and thicker stress cables, mainly dorsal fibres and trans-
verse arcs. This was accompanied by markedly increased cell adhesion and
focal adhesion size. Concomitantly, AMPKα1 activation also resulted in a
sustained activation of RhoA that was associated with a significant increase in
MLC phosphorylation and its colocalization with transverse arcs.
Conclusion: We postulate that A-769662 counteracts HCF migration
through an AMPK-dependent sustained activation of the RhoA/MLC pathway,
promoting actin polymerization and contraction. Myosin II-generated tension
into FA is expected to promote their maturation and subsequently alter migra-
tion.
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Atrial natriuretic peptide antifibrotic properties are mainly described in
cardiac myocytes or in induced cardiac myofibroblasts (Angiotensin II or
TGF-β induced differentiation). In the present work, we investigate the
effects of ANP/NPRA/cGMP system in modulating rat cardiac fibroblasts
function. Cardiac fibroblasts were isolated from adult Wistar male rats and
cultured in the presence of serum in order to induce fibroblasts differentia-
tion. Cultures were then treated with ANP (1μM), 8-Br-cGMP (100μM) or
IBMX (100μM), a non-specific phosphodiesterases inhibitor. ANP signifi-
cantly decreased proliferation rate and collagen secretion. Its effect was
mimicked by the cGMP analog, while combining ANP with 8-BrcGMP did
not lead to additional effects. Moreover intracellular cGMP levels were ele-
vated when cells were incubated with ANP confirming that ANP intracel-
lular pathway is mediated by cGMP. Additionally, immunoblotting and
immunofluorescence were used to confirm the presence of guanylyl cyclase
specific natriuretic peptide receptors A and B. Finally we scanned specific
cGMP dependent PDEs via RT-qPCR, and noticed that inhibiting all PDEs
led to an important decrease in proliferation rate. Effect of ANP became
more prominent after 10 culture days, confirming the importance of ANP in
fibroblasts to myofibroblasts differentiation. Uncovering cellular aspects of
ANP/NPRA/cGMP signaling system provided more elements to help under-
stand cardiac fibrotic process.
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Mechanistic target of rapamycin (mTOR) is a central regulator of cell
growth, proliferation, survival and metabolism. mTOR inhibition is increa-
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singly used in antitumoral therapies and mTOR inhibition with rapamycin
was shown to be cardioprotective during aging and cardiac stress. Studies
in genetic mice models have shown that mTOR is essential for heart devel-
opment and cardiac function in adult. However, mTOR functions during
postnatal cardiac development are not fully elucidated. We have therefore
generated a cardiac-specific mTOR knockout mouse using α-MHC-Cre
mice leading to mTOR inactivation in early postnatal mouse myocardium.
The mutant mice develop a severe lethal dilated cardiomyopathy due to
defects in cardiomyocyte growth, survival and subsequent fibrosis. In
contrast to adult myocardium, both mTORC1 and mTORC2 activities are
impaired in juvenile heart, as shown by hypophosphorylation of the trans-
lation inhibitor 4E-BP1 and loss of the cardioprotective AKTS473 phos-
phorylation. We find that translation initiation defects and altered ribosome
biogenesis both contribute to impaired cardiomyocyte growth. In addition,
we show that increased apoptosis is associated with activation of JNK
kinase and p53 accumulation. Moreover mTORcmKO hearts display a
strong decreased expression of the primary oxygen carrier, myoglobin, and
HIF1α accumulation suggesting hypoxia. However, mTORcmKO hearts do
not display HIF1 hypoxic response consistently with mTOR being essential
for HIF1-dependant trancriptionnal activity. These observations indicate
that hypoxia-induced apoptosis likely contribute to DCM in mTORcmKO
mice. Altogether, our results demonstrate that mTOR is a key regulator of
cardiomyocyte growth, viability and oxygen supply in early postnatal myo-
cardium. Our findings highlight potential cardiotoxicity of new mTOR
inhibitors and the importance to set up optimal treatments in cardiology to
both target mTOR hypertrophic functions and maintain adequate oxygen
supply.
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The bone derived hormone fibroblast growth factor 23 (FGF23) and its co-
receptor Klotho represent a novel endocrine axis regulating mineral metabo-
lism in health and disease.
FGF23-Klotho signalling inhibits renal phosphate reabsorption and activa-
tion of vitamin D, and reduces secretion of parathyroid hormone. Serum levels
of FGF23 rise in chronic kidney disease (CKD). In contrast, tissue expression
of Klotho decreases in parallel with CKD progression and reaches low or
undetectable levels in end stage renal disease.
Numerous studies identify elevated FGF23 as a predictor of adverse clin-
ical outcome. In particular, elevated FGF23 has recently been associated with
greater risks of major cardiovascular events and mortality.
However, there have been very few studies that have attempted to
address the direct effects of FGF23 on myocardium. Moreover whether
Klotho is involved in FGF23 – mediated actions on cardiomyocytes is still
unclear.
In this context, we investigate the role of FGF23 and Klotho in adult rat
ventricular myocytes (ARVMs). Using video-edge-detection, epifluorescent
microscopy and an Ionoptix® system, performed in isolated cardiomyocytes
subjected to FGF23 or Klotho alone, or in association, we showed that FGF23
increases cell size and cell shortening in ARVMs, and induces arrhythmia in
the presence of Isoprenaline. In addition Klotho prevents FGF23 effects on
adult cardiomyocytes. Indeed, ARVMs subjected to Klotho showed marked
protection from FGF23-induced hypertrophic responses and from FGF23-
induced arrhythmias in the presence of Isoprenaline.
Altogether these preliminary data provide a direct evidence of the role
FGF23 in adult cardiomyocytes and suggest that Klotho may have a beneficial
effect in preventing adverse cardiovascular outcomes in patients with or
without CKD.
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The rough endoplasmic reticulum (rER) is the site for synthesis, folding and
quality control of secreted and membrane proteins. Impairment of ER function in
response to stresses such as oxidative stress, disruption of calcium homeostasis or
ischemia causes the accumulation of misfolded proteins in the rER lumen,
resulting in ER stress. Over the past decade, ER stress has emerged as an impor-
tant mechanism involved in the pathogenesis of cardiovascular diseases including
heart failure. However, the molecular mechanisms underlying the contribution of
ER stress to cardiac dysfunction remain poorly understood. In the present study,
we evaluated the effect of the ER stressor tunicamycin (TN) on cardiac function
in mice. TN injection (2mg/kg, 72h) induced a significant impairment of systolic
function as indicated by the decrease in ejection fraction and fractional shortening.
However, the heart rate, left ventricular internal diameters in diastole and systole
and wall thickness were not affected. Transmission electron microscopy analysis
revealed that TN induced an important ultrastructural remodeling of the cardiomy-
ocytes with an increase in the occurrence of rER. Whereas rER was essentially
located near the nucleus in cardiomyocytes of control mice, we observed an
expansion of the rER network near sarcomeres and around T-tubules and mito-
chondrial clusters after TN treatment. In addition, mitochondrial structure and net-
work were also disorganized. When measured in skinned fibers, the rate of
mitochondrial oxidation was slower and an impairment of the function of the cre-
atine kinase energy shuttle was observed in response to TN. In addition, ER stress
triggered a metabolic remodeling characterized by a shift from fatty acid to glyco-
genic substrates consumption. Taken together our results show for the first time
that the cytoarchitectural and metabolic alterations of cardiomyocytes contribute to
the cardiac injury induced by ER stress.
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The heart is highly energy-dependent with most of its energy provided by
mitochondria. Mitochondria also play a role in many essential cellular processes
including metabolite synthesis, redox balance, calcium homeostasis and cell death.
Therefore, maintaining a functional population of mitochondria is critical for car-
diac function and identification of novel regulatory mechanisms. Recently, a sol-
uble adenylyl cyclase (sAC) has been revealed to serve as a local source of the
second messenger cAMP in the mitochondrial matrix in response to bicarbonate
and calcium. PDE2A, a cGMP-stimulated cAMP-hydrolyzing phosphodiesterase
(PDE), was also shown to be expressed in the mitochondrial matrix of liver and
brain. To gain new insights into the control of mitochondrial pool of cAMP, we
investigated the role of various isoforms of PDEs in isolated cardiac mitochondria.
Western blot analysis of PDE protein expression revealed positive bands for
PDE2A, 3A, 4A and 4B subtypes in cardiac mitochondria. Basal cAMP-degrading
enzymatic activities were determined by radioenzymatic assay in cardiac mito-
chondrial lysates with 1μm cAMP as substrate. PDE2 represented the largest mito-
chondrial cAMP PDE activity (35% of total) and its activity was enhanced ~2-fold
by 5μM cGMP and was inhibited by the PDE2 inhibitor, Bay 60-7550 (100nm).
PDE3 and PDE4 activities represented, respectively, 30% and 25% of total, and
they were inhibited by their respective inhibitors, cilostamide (1μm) and Ro 20-
1724 (10 μM). Accordingly, measurements by ELISA of mitochondrial cAMP
levels confirmed that inhibition of PDE2, 3 and 4 families leads to an increase in
cAMP level. In conclusion, at least three PDE families and four PDE subtypes are
located in the cardiac mitochondrial matrix, participating to a local signaling
pathway with sAC to control cAMP level. Our findings unravel a cAMP signaling
cascade in cardiac mitochondria which may have implications for the metabolic
control of cardiac function.
